Protai Company

Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases. Protai's platform has made a leap in solving how drug candidates are created and validated, facilitating quicker and more advanced drug discovery.
Industry: Early Drug Development
Headquarters: Tel Aviv, Tel Aviv, Israel
Founded Date: 2021-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 2
Total Funding: 8000000
Last Funding Date: 2022-01-05
Last Funding Type: Seed

Visit Website
contact@protai.bio
Register and Claim Ownership